Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease
Summary
- Management of cardiovascular disease in patients with HIV is based on research conducted in the general population
- Recommended approach involves risk-factor reduction, use of antiplatelet therapy, beta-blockers, angiotensin inhibitors or angiotensin receptor blockers, statins or antilipidic agents, and other interventions where necessary (Table 12)[Smith 2006; ACC/AHA 2013]
- Referral to a cardiologist is recommended in patients with established coronary artery disease or when baseline evaluation is suggestive of disease
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content